4.6 (226) · € 24.00 · En Stock
Abbott announced today that the U.S. Food and Drug Administration (FDA) has cleared the FreeStyle® Libre 2 iOS application for use with compatible iPhones1, providing a comprehensive digital
CGM for Employers & Employees
FreeStyle Libre 2 System
Abbott to hike production of lower-cost glucose monitors as diabetes soars
Abbott FreeStyle Libre 2 iOS App Receives FDA Approval - JDRF
Freestyle Libre 2 app review: We finally have alerts - Reviewed
Wearable Electrochemical Glucose Sensors in Diabetes Management: A Comprehensive Review
Freestyle Libre 2 app review: We finally have alerts - Reviewed
Download the FreeStyle Libre 2 App & LibreLink App
Abbott's Freestyle® Libre 2 IOS App Cleared In U.S., Providing a Seamless Digital Experience to Simplify Diabetes Management